Overview

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
To evaluate efficacy of the dual therapy of atorvastatin + amlodipine vs. amlodipine alone .
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Amlodipine
Atorvastatin
Atorvastatin Calcium